Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand

BACKGROUND: The national Human Papillomavirus (HPV) Immunisation Programme in New Zealand was introduced in 2008, and involves routine vaccination of girls 12–13 years with a catch-up for females aged up to 19 years. The aims of this study were to measure the pre-vaccination prevalence of oncogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonella, Leonardo M, Lewis, Hazel, Smith, Megan, Neal, Harold, Bromhead, Collette, Canfell, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607885/
https://www.ncbi.nlm.nih.gov/pubmed/23452957
http://dx.doi.org/10.1186/1471-2334-13-114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607885/
https://www.ncbi.nlm.nih.gov/pubmed/23452957
http://dx.doi.org/10.1186/1471-2334-13-114

Ejemplares similares